International Business Times, Singapore Edition
IBT
  • Asia Pacific
  • US
  • Technology
  • Business
  • Fintech
  • Sports
  • Entertainment
  • Science
  • Celebsway
  • Lifestyle

Health

    Covaxin

    Phase 3 Trial in US Shows India's Covaxin is 100% Effective Against Severe Covid-19

    Results from a Phase 2 trial of Covaxin indicate that it is safe and well tolerated, while unpublished interim results from the Phase 3 trial indicate that the vaccine has 78 per cent efficacy against symptomatic disease.
    Jul 1, 2021
    By IANS
    Healthcare

    Moderna Says its Covid-19 Vaccine Shows Promise in Lab Setting Against Variants

    The vaccine produced neutralising titers against all variants tested, including the Delta variant.
    Jun 30, 2021
    By IANS
    Covid 19 Coronavirus Vaccine Jab mNRA

    New Research Shows People who Took the mNRA Vaccine Could Be Protected For Life

    Study shows people who took mNRA vaccines such as Pfizer-BioNTech and Moderna could be protected for many years from the virus.
    Jun 29, 2021
    By Vinod DSouza
    Dr Anthony Fauci

    US to Soon See Explosive Outbreak of Delta Variant: Epidemiologist

    According to the CDC, the variant now represents at least 20 per cent of Covid cases in the US,
    Jun 29, 2021
    By IANS
    Coronavirus
    Coronavirus Covid 19 Vaccine Jab Medical

    Mother-of-three Dies 22 Days After Receiving AstraZeneca Vaccine that Caused Blood Clots in Brain

    The woman suffered from a rare and catastrophic condition after receiving the first dose of AstraZeneca vaccine.
    Jun 28, 2021
    By Vinod DSouza
    SARS-CoV-2 Spike Protein

    Spike Protein Changes in COVID Variants Can Make Vaccine Ineffective

    The study also found that mutations in the Beta variant make the spike less effective in binding to ACE2.
    Jun 28, 2021
    By IANS
    Coronavirus
    Fading sense of smell may suggest early death

    Covid-19 Survivors May Take a Year to Get Back Taste, Smell: Study

    Researchers from the University Hospitals of Strasbourg in France followed 97 Covid-19 patients who lost their sense of taste and smell for an entire year.
    Jun 27, 2021
    By IANS
    Pfizer-BioNTech vaccine

    Covid Virus Can Evade Vaccines, Find Alternate Way to Infect Cells

    The discovery shows that the virus can change in unexpected ways and find new ways to cause infection.
    Jun 26, 2021
    By IANS
    Coronavirus
    AstraZeneca

    AstraZeneca Says its Vaccine Shows 92% Effectiveness Against Delta Variant

    The analysis included 14,019 cases of the Delta variant – 122 of whom were hospitalised – between 12 April and 4 June.
    Jun 24, 2021
    By IBTimes APAC Desk
    Coronavirus
    Novel Coronavirus

    Russia Develops Covid Antibody Test System for Animals

    The procedure was tested during the research of biological materials of pets, agricultural and fur animals.
    Jun 24, 2021
    By IANS
    Coronavirus
    Vaccination

    Freedom Delayed? US Will Fall Short of Biden's July 4 Vaccination Goal

    Biden announced in early May the goal to administer at least one dose of a Covid-19 vaccine to 70 per cent of American adults by July 4.
    Jun 23, 2021
    By IANS
    Coronavirus
    Novel Coronavirus

    Covid Infections in US Will Surge if Vaccination Rates Lag: Ex-FDA Chief

    The CDC has elevated the Delta strain from "variant of interest" to "variant of concern".
    Jun 21, 2021
    By IANS
    Coronavirus
    child covid-19

    After Reining in Covid-19, Israel Reports Outbreak in 2 Schools, 45 Students Infected

    An extensive testing operation, which began after one of the middle school students had been tested positive, revealed the outbreak.
    Jun 20, 2021
    By IANS
    Coronavirus
    Coronavirus Covid 19 Face Mask

    Here Are The 4 New 'Delta Variant' Covid-19 Symptoms You Have to Look Out For

    The delta variant has brought out newer and dangerous symptoms in Covid-19 patients not previously reported before.
    Jun 19, 2021
    By Vinod DSouza
    Herd immunity

    Here's Why Israel is Giving Palestine a Million Doses of Vaccine Doses Nearing Expiry Date

    In Israel, more than 55 percent of the population have received both doses of the vaccine, while in Palestinian, only about 260,000 people been vaccinated.
    Jun 18, 2021
    By Jacob J
    Prev 27 28 29 30 31 32 33 34 35 36 Next
    BLOGS AND FEATURES
    Mahshad Nasr Esfahani

    Research Addressing the STEM Workforce Crisis Through Multilingual Education

    By Alexander Maxwell

    Mahshad Nasr Esfahani said Fostering polyglottal erudition catalyzes the amelioration of gender disparities, engendering a paradigm shift towards equitable representation in STEM vocations

    Research Addressing the STEM Workforce Crisis Through Multilingual Education

    By Alexander Maxwell
    GOQii

    Gamifying Healthcare to Incentivize Healthy, Sustainable Habits

    By IBT Desk

    GOQii is leading app allows users to immerse themselves in their fitness journeys with gamification techniques

    Gamifying Healthcare to Incentivize Healthy, Sustainable Habits

    By IBT Desk
    Pharma Industry

    Enhancing Pharma Industry's Patient Program Capabilities with Advanced Master Data Management Application

    By Amit Singh

    Modern master data management applications will be essential to maintain competitiveness and deliver optimal patient care.

    Enhancing Pharma Industry's Patient Program Capabilities with Advanced Master Data Management Application

    By Amit Singh
    Previous 1 of Next

    News

    • India
    • US
    • World
    • Business
    • Technology
    • Sports
    • Entertainment
    • Auto
    • Photos
    • Video

    POLICIES

    • Advertise with us
    • Permission
    • Syndication
    • Terms of service
    • Privacy & Cookie Policy

    ABOUT

    • About us
    • Brand
    • Careers
    • Site Navigation
    • Contact

    EDITIONS

    • Australia
    • India
    • Singapore
    • U.K.
    • U.S.

    Follow US

    •   Facebook
    •   Twitter
    •   Pinterest
    •   Rss
    IBTimes
    © Copyright 2025, IBTimes Co., Ltd. All Rights Reserved.